Neurosense Therapeutics (NRSN) CEO Issues Q3 2023 Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Neurosense Therapeutics (NRSN) CEO Issues Q3 2023 Update
(NASDAQ: NRSN) Delayed: 0.35 +0.02 (6.06%)
Previous Close $0.33    52 Week High $ 
Open $0.35    52 Week Low $ 
Day High $0.35    P/E N/A 
Day Low $0.33    EPS $ 
Volume 230,568